The management of gout
- PMID: 8552148
- DOI: 10.1056/NEJM199602153340707
The management of gout
Abstract
We now have sufficient knowledge to be able to identify the factors contributing to hyperuricemia in most patients with gout. Some of these factors, such as obesity, a high-purine diet, regular alcohol consumption, and diuretic therapy, may be correctable. In patients with persistent hyperuricemia, regular medication should lower the serum urate concentration to an optimal level. The continuing challenge is to educate patients about correctable factors and the importance of regular medication and ensure their compliance so that attacks of gout do not recur.
Comment in
-
Management of gout.N Engl J Med. 1996 Jun 6;334(23):1543; author reply 1543-4. doi: 10.1056/NEJM199606063342313. N Engl J Med. 1996. PMID: 8618614 No abstract available.
-
Management of gout.N Engl J Med. 1996 Jun 6;334(23):1543; author reply 1543-4. N Engl J Med. 1996. PMID: 8618615 No abstract available.
Similar articles
-
Colchicine and other drugs for gout.Med Lett Drugs Ther. 2009 Nov 30;51(1326):93-4. Med Lett Drugs Ther. 2009. PMID: 20224523 Review. No abstract available.
-
Drugs for gout.Med Lett Drugs Ther. 2014 Mar 17;56(1438):22-4. Med Lett Drugs Ther. 2014. PMID: 24791281 No abstract available.
-
The current state of care in gout: Addressing the need for better understanding of an ancient disease.J Am Acad Nurse Pract. 2010 Nov;22 Suppl 1:623-36. doi: 10.1111/j.1745-7599.2010.00556.x. Epub 2010 Nov 3. J Am Acad Nurse Pract. 2010. PMID: 21054636
-
Gout.JAMA. 2003 Jun 4;289(21):2857-60. doi: 10.1001/jama.289.21.2857. JAMA. 2003. PMID: 12783917 Review. No abstract available.
-
[Therapeutic criteria in hyperuricemia].Rev Clin Esp. 2001 Feb;201(2):85-7. doi: 10.1016/s0014-2565(01)70756-4. Rev Clin Esp. 2001. PMID: 11345611 Spanish. No abstract available.
Cited by
-
Serum Uric Acid Concentration in Patients with Cerebrovascular Disease (Ischemic Stroke and Vascular Dementia).Med Arch. 2020 Apr;74(2):95-99. doi: 10.5455/medarh.2020.74.95-99. Med Arch. 2020. PMID: 32577048 Free PMC article.
-
Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout.Core Evid. 2010 Jun 15;4:25-36. doi: 10.2147/ce.s5999. Core Evid. 2010. PMID: 20694062 Free PMC article.
-
Management of acute and chronic gouty arthritis: present state-of-the-art.Drugs. 2004;64(21):2399-416. doi: 10.2165/00003495-200464210-00003. Drugs. 2004. PMID: 15481999 Review.
-
The serum urate-lowering impact of weight loss among men with a high cardiovascular risk profile: the Multiple Risk Factor Intervention Trial.Rheumatology (Oxford). 2010 Dec;49(12):2391-9. doi: 10.1093/rheumatology/keq256. Epub 2010 Aug 30. Rheumatology (Oxford). 2010. PMID: 20805117 Free PMC article.
-
Preferential inhibition of xanthine oxidase by 2-amino-6-hydroxy-8-mercaptopurine and 2-amino-6-purine thiol.BMC Biochem. 2007 May 18;8:8. doi: 10.1186/1471-2091-8-8. BMC Biochem. 2007. PMID: 17511860 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical